A breakthrough against resistant leukemia in children supported by the Charles-Bruneau Foundation

A team from CHU Sainte-Justine recently created cells to cure rare and resistant leukemias in children. Called ThINKK, these new cells provide hope for treating dozens of critically ill Canadian children, for whom traditional therapies do not work. Efforts are underway to make this treatment available in clinical trials as early as 2024, and the current preliminary results are...

Read more